SEARCH

SEARCH BY CITATION

References

  • 1
    Werlin SL, Chusid MJ, Caya J, Oechler HW. Colitis in chronic granulomatous disease. Gastroenterology 1982; 82: 32831.
  • 2
    Lindahl JA, Williams FH, Newman SL. Small bowel obstruction in chronic granulomatous disease. J Pediatr Gastroenterol Nutr 1984; 3: 63740.
  • 3
    Isaacs D, Wright VM, Shaw DG, Raafat F, Walker-Smith JA. Chronic granulomatous disease mimicking Crohn's disease. J Pediatr Gastroenterol Nutr 1985; 4: 498501.
  • 4
    Ahlin A, De Boer M, Roos D, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 1995; 84: 138694.
  • 5
    Baehner RL. Chronic granulomatous disease of childhood: clinical, pathological, biochemical, molecular, and genetic aspects of the disease. Pediatr Pathol 1990; 10: 14353.
  • 6
    Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr 1995; 126: 1435.
  • 7
    Sloan JM, Cameron CH, Maxwell RJ, McCluskey DR, Collins JS. Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut 1996; 38: 61922.
  • 8
    Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Brief report: Treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 1992; 326: 16669.
  • 9
    Sanderson IR, Bisset WM, Milla PJ, Leonard JV. Chronic inflammatory bowel disease in glycogen storage disease type 1b. J Inherit Metab Dis 1991; 14: 7716.
  • 10
    D'Agata ID, Paradis K, Chad Z, Bonny Y, Seidman E. Leukocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 1996; 39: 6058.
  • 11
    Ishii E, Matui T, Iida M, Inamitu T, Ueda K. Chediak-Higashi syndrome with intestinal complication. Report of a case. J Clin Gastroenterol 1987; 9: 5568.
  • 12
    Knudtzon J, Svane S. Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand 1988; 223: 3758.
  • 13
    Vannier J, Arnaud-Battndier F, Ricour C, et al. Neutropenia primitive et congenital et maladie de Crohn. Arch Fr Pediatr 1982; 39: 36770.
  • 14
    Lamport RD, Katz S, Eskreis D. Crohn's disease associated with cyclic neutropenia. Am J Gastroenterol 1992; 87: 163842.
  • 15
    Stevens C, Peppercorn MA, Grand RJ. Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 1991; 13: 32830.
  • 16
    Harewood G, Loftus E, Sanborn W, Tremaine W. Concurrent inflammatory bowel disease and the leukemias. Gastroenterology 1998; 114: A992.
  • 17
    Harewood G, Loftus E, Sanborn W, Tremaine W. Concurrent inflammatory bowel disease and myelodysplastic syndromes. Gastroenterology 1998; 114: A991.
  • 18
    Schulman H, Weizman Z, Barki Y, Maor E, Hertzanu Y. Inflammatory bowel disease in glycogen storage disease type 1b. Pediatr Radiol 1995; 25: S1602.
  • 19
    Korzenik J, Dieckgraefe B. Crohn's disease: an immunodeficiency disease? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 2000; 45: 11219.
  • 20
    Fischer A, Segal AW, Seger R, Weening RS. The management of chronic granulomatous disease. Eur J Pediatr 1993; 152: 8969.
  • 21
    Roe TF, Thomas DW, Gilsanz V, Isaacs H Jr, Atkinson JB. Inflammatory bowel disease in glycogen storage disease type Ib [see comments]. J Pediatr 1986; 109: 559.
  • 22
    Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 1998; 42: 12730.
  • 23
    Hurst D, Kilpatrick L, Becker J, et al. Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease-1b. Am J Pediatr Hematol Oncol 1993; 15: 716.
  • 24
    Schroten H, Roesler J, Breidenbach T, et al. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr 1991; 119: 74854.
  • 25
    McCawley LJ, Korchak HM, Douglas SD, et al. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1b: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediatr Res 1994; 35: 8490.
  • 26
    Kath R, Hartmann M, Hoffken K. Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignancies. J Cancer Res Clin Oncol 1998; 124: 28890.
  • 27
    Gerber A, Struy H, Lippert GW, Ansorge S, Schulz H. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in non-neutropenic surgical intensive care patients. J Interferon Cytokine Res 2000; 20: 108390.
  • 28
    Pitrak D. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on the bactericidal functions of neutrophils. Curr Opin Hematol 1997; 4: 18390.
  • 29
    Allen R, Stevens P, Price T, Chatta G, Dale D. In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. J Infect Dis 1997; 175: 118492.
  • 30
    Gottlieb R, Giesing H, Zhu J, Engler R, Babior B. Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase. Proc Natl Acad Sci U S A 1995; 92: 59658.
  • 31
    Elmgreen J. Complement and function of neutrophils in chronic inflammatory bowel disease. Dan Med Bull 1986; 33: 2228.
  • 32
    Freedman MH. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol 1997; 4: 21724.
  • 33
    Dejacoa C, Lichtenbergera C, Miehslera W, et al. An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 2003; 68: 6370.
  • 34
    Fata F, Myers P, Addeo J, Grinberg M, Nawabi I, Cappell MS. Cyclic neutropenia in Crohn's ileocolitis: efficacy of granulocyte colony-stimulating factor. J Clin Gastroenterol 1997; 24: 2536.
  • 35
    Vaughan D, Drumm B. Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease [letter]. N Engl J Med 1999; 340: 23940.
  • 36
    Segal AW, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet 1976; 2: 21921.
  • 37
    O'Morain C, Segal AA, Walker D, Levi AJ. Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease. Gut 1981; 22: 81722.
  • 38
    Verspaget HW, Pena AS, Weterman IT, Lamers CB. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988; 29: 2238.
  • 39
    Curran FT, Youngs DJ, Allan RN, Keighley MR. Candidacidal activity of Crohn's disease neutrophils. Gut 1991; 32: 5560.
  • 40
    Gionchetti P, Campieri M, Guarnieri C, et al. Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission. Dig Dis Sci 1994; 39: 5504.
  • 41
    Wandall JH. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis. Scand J Gastroenterol 1985; 20: 11516.
  • 42
    Ogura Y, Bonen D, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 6036.
  • 43
    Terashima T, Soejima K, Waki Y, et al. Neutrophils activated by granulocyte colony-stimulating factor suppress tumor necrosis factor-alpha release from monocytes stimulated by endotoxin. Am J Respir Cell Mol Biol 1995; 13: 6973.
  • 44
    Pan L, Delmonte JJ, Jalonen C, Ferrara J. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 44229.
  • 45
    Hartung T, Docke W, Gantner F, et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 24829.